Former President Joe Biden diagnosed with ‘aggressive’ form of prostate cancer

Former President Joe Biden diagnosed with ‘aggressive’ form of prostate cancer


Former President Joe Biden speaks during the Advocates, Counselors, and Representatives for the Disabled bipartisan conference at the Sofitel Chicago Magnificent Mile on Tuesday, April 15, 2025.

Eileen T. Meslar | Chicago Tribune | Getty Images

Former President Joe Biden has been diagnosed with prostate cancer, his office said Sunday.

Biden was seen last week by doctors after urinary symptoms and a prostate nodule was found. He was diagnosed with prostate cancer on Friday, with the cancer cells having spread to the bone. His office said he has stage 9 cancer.

“While this represents a more aggressive form of the disease, the cancer appears to be hormone-sensitive which allows for effective management,” his office said. “The President and his family are reviewing treatment options with his physicians.”

Prostate cancers are given a score called a Gleason score that measures, on a scale of 1 to 10, how the cancerous cells look compared with normal cells. Biden’s score of 9 suggests his cancer is among the most aggressive.

When prostate cancer spreads to other parts of the body, it often spreads to the bones. Metastasized cancer is much harder to treat than localized cancer because it can be hard for drugs to reach all the tumors and completely root out the disease.

However, when prostate cancers need hormones to grow, as in Biden’s case, they can be susceptible to treatment that deprives the tumors of hormones.

The health of Biden, 82, was a dominant concern among voters during his time as president. After a calamitous debate performance in June while seeking reelection, Biden abandoned his bid for a second term. Then-Vice President Kamala Harris became the nominee and lost to Republican Donald Trump, who returned to the White House after a four-year hiatus.

But in recent days, Biden rejected concerns about his age despite reporting in the new book “Original Sin” by Jake Tapper and Alex Thompson that aides had shielded the public from the extent of his decline while serving as president.

In February 2023, Biden had a skin lesion removed from his chest that was a basal cell carcinoma, a common form of skin cancer. And in November 2021, he had a polyp removed from his colon that was a benign, but potentially pre-cancerous lesion.

In 2022, Biden made a “cancer moonshot” one of his administration’s priorities with the goal of halving the cancer death rate over the next 25 years. The initiative was a continuation of his work as vice president to address a disease that had killed his older son, Beau.



Source

Trump approves U.S. Steel merger with Japan’s Nippon after companies sign national security agreement
World

Trump approves U.S. Steel merger with Japan’s Nippon after companies sign national security agreement

US President Donald Trump receives a gold helmet with his name on it during a visit to US Steel – Irvin Works in West Mifflin, Pennsylvania, May 30, 2025, to mark the ‘partnership’ between Nippon Steel and US Steel. Saul Loeb | AFP | Getty Images President Donald Trump issued an executive order on Friday […]

Read More
Israel-Iran conflict will hang over markets next week, with Fed meeting at hand
World

Israel-Iran conflict will hang over markets next week, with Fed meeting at hand

The Israel-Iran conflict will continue to hang over the stock market next week, as investors wait and see whether there will be an escalation in the region. Traders will also be awaiting the latest Federal Reserve meeting. Though the initial stock response to the attack was subdued, equity losses deepened on Friday afternoon. The Dow […]

Read More
European stocks fell after Israel launches air strikes on Iran
World

European stocks fell after Israel launches air strikes on Iran

European stocks fall after Israel launches air strikes on Iran European stock markets closed in the red after Israel launched air strikes on Iran. The Stoxx Europe 600 index provisionally closed 1% lower. Germany’s DAX and France’s CAC 40 also fell a little more than 1.1%. The U.K.’s FTSE 100, which had initially rallied, also […]

Read More